{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:10:46Z","timestamp":1781277046762,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>On December 7, 2022, China switched from dynamic zeroing strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to reopening. A nationwide SARS-CoV-2 epidemic emerged rapidly. The effect of smoking on SARS-CoV-2 infection remains unclear. We aimed to retrospectively investigate the relationship between smoking and coronavirus disease 2019 (COVID-19) using a community-based cohort of smokers and non-smokers. We included participants from a pre-pandemic cohort with a prolonged follow-up period. Data on smoking status, body mass index, and history of other diseases were collected from health examination and consultation clinic records. Cox regression analysis was used to identify the relationship between groups and SARS-CoV-2 infection over time. We analysed 218 male patients with varied smoking statuses (46.3% current or ex-smokers; average age 68.63\u2009\u00b1\u20099.81\u00a0years). Two peaks in the epidemic were observed following the December 2022 outbreak. At the end of the second peak, non-smokers, current smokers, and ex-smokers had primary infection rates increase to 88.0%, 65.1%, and 81.0%, respectively, with a significant difference between the groups. Current smoking significantly protected against SARS-CoV-2 infection (HR 0.625, 95% CI 0.402\u20130.970, <jats:italic>p<\/jats:italic>\u2009=\u20090.036). Further analyses showed that the prevalence of pneumonia in the unvaccinated, older, diabetic, and non-smoking groups was significantly higher than that in the other groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Our study suggests a potential association between smoking and a reduced risk of SARS-CoV-2 infection and pneumonia. This indicates that nicotine and ACE2 play important roles in preventing COVID-19 and its progression. We suggest smokers use nicotine replacement therapy during hospitalization for COVID-19.<\/jats:p>","DOI":"10.1007\/s11739-024-03713-5","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T08:11:32Z","timestamp":1724314292000},"page":"2141-2149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults"],"prefix":"10.1007","volume":"19","author":[{"given":"Xiaomeng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5782-1570","authenticated-orcid":false,"given":"Xuefeng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"3713_CR1","unstructured":"WHO COVID-19 Dashboard (2020). Geneva: World Health Organization. https:\/\/covid19.who.int\/ Accessed 31 Dec 2023"},{"issue":"4","key":"3713_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.15585\/mmwr.mm7104e4","volume":"71","author":"AD Iuliano","year":"2022","unstructured":"Iuliano AD et al (2022) Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, december 2020-january 2022. MMWR Morb Mortal Wkly Rep 71(4):146\u2013152","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"3713_CR3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-022-01855-7","volume":"28","author":"J Cai","year":"2022","unstructured":"Cai J et al (2022) Modeling transmission of SARS-CoV-2 omicron in China. Nat Med 28(7):1468\u20131475","journal-title":"Nat Med"},{"issue":"6585","key":"3713_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.abn1755","volume":"375","author":"DM Altmann","year":"2022","unstructured":"Altmann DM, Boyton RJ (2022) COVID-19 vaccination: the road ahead. Science 375(6585):1127\u20131132","journal-title":"Science"},{"issue":"3","key":"3713_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00059-023-05183-5","volume":"48","author":"J Ge","year":"2023","unstructured":"Ge J (2023) The COVID-19 pandemic in China: from dynamic zero-COVID to current policy. Herz 48(3):226\u2013228","journal-title":"Herz"},{"issue":"10","key":"3713_CR6","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jiph.2020.07.006","volume":"13","author":"AE Iyanda","year":"2020","unstructured":"Iyanda AE et al (2020) A retrospective cross-national examination of COVID-19 outbreak in 175 countries: a multiscale geographically weighted regression analysis (January 11-June 28, 2020). J Infect Public Health 13(10):1438\u20131445","journal-title":"J Infect Public Health"},{"issue":"9","key":"3713_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/ntr\/ntaa121","volume":"22","author":"P Tsigaris","year":"2020","unstructured":"Tsigaris P, Teixeira da Silva JA (2020) Smoking prevalence and COVID-19 in Europe. Nicotine Tob Res 22(9):1646\u20131649","journal-title":"Nicotine Tob Res"},{"issue":"7821","key":"3713_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ et al (2020) Factors associated with COVID-19-related death using openSAFELY. Nature 584(7821):430\u2013436","journal-title":"Nature"},{"issue":"e2","key":"3713_CR9","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1136\/tobaccocontrol-2020-055933","volume":"30","author":"SE Jackson","year":"2021","unstructured":"Jackson SE et al (2021) COVID-19, smoking and inequalities: a study of 53 002 adults in the UK. Tob Control 30(e2):e111\u2013e121","journal-title":"Tob Control"},{"issue":"9","key":"3713_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/CM9.0000000000000775","volume":"133","author":"W Liu","year":"2020","unstructured":"Liu W et al (2020) Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) 133(9):1032\u20131038","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"3713_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233147","volume":"15","author":"JS Alqahtani","year":"2020","unstructured":"Alqahtani JS et al (2020) Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE 15(5):e0233147","journal-title":"PLoS ONE"},{"issue":"5","key":"3713_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1389202922666210921101728","volume":"22","author":"R Kumar","year":"2021","unstructured":"Kumar R et al (2021) Accumulating impact of smoking and co-morbidities on severity and mortality of COVID-19 infection: a systematic review and meta-analysis. Curr Genomics 22(5):339\u2013352","journal-title":"Curr Genomics"},{"issue":"1","key":"3713_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","volume":"21","author":"ZG Dessie","year":"2021","unstructured":"Dessie ZG, Zewotir T (2021) Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 21(1):855","journal-title":"BMC Infect Dis"},{"key":"3713_CR14","doi-asserted-by":"publisher","first-page":"1213077","DOI":"10.3389\/fmed.2023.1213077","volume":"10","author":"MY Birhanu","year":"2023","unstructured":"Birhanu MY, Jemberie SS (2023) Mortality rate and predictors of COVID-19 inpatients in Ethiopia: a systematic review and meta-analysis. Front Med (Lausanne) 10:1213077","journal-title":"Front Med (Lausanne)"},{"key":"3713_CR15","first-page":"58","volume":"18","author":"EJ Grundy","year":"2020","unstructured":"Grundy EJ et al (2020) Smoking, SARS-CoV-2 and COVID-19: a review of reviews considering implications for public health policy and practice. Tob Induc Dis 18:58","journal-title":"Tob Induc Dis"},{"issue":"12","key":"3713_CR16","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1002\/jmv.27233","volume":"93","author":"M Saadatian-Elahi","year":"2021","unstructured":"Saadatian-Elahi M et al (2021) Tobacco smoking and severity of COVID-19: experience from a hospital-based prospective cohort study in Lyon. France J Med Virol 93(12):6822\u20136827","journal-title":"France J Med Virol"},{"issue":"1","key":"3713_CR17","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1186\/s12889-021-11579-x","volume":"21","author":"R Patanavanich","year":"2021","unstructured":"Patanavanich R, Glantz SA (2021) Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis. BMC Public Health 21(1):1554","journal-title":"BMC Public Health"},{"issue":"10258","key":"3713_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBDRF Collaborators","year":"2020","unstructured":"Collaborators GBDRF (2020) Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396(10258):1223\u20131249","journal-title":"Lancet"},{"issue":"9","key":"3713_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/hr.2013.57","volume":"36","author":"CS Sheng","year":"2013","unstructured":"Sheng CS et al (2013) Prevalence, awareness, treatment and control of hypertension in elderly Chinese. Hypertens Res 36(9):824\u2013828","journal-title":"Hypertens Res"},{"issue":"5","key":"3713_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11739-020-02355-7","volume":"15","author":"K Farsalinos","year":"2020","unstructured":"Farsalinos K, Barbouni A, Niaura R (2020) Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med 15(5):845\u2013852","journal-title":"Intern Emerg Med"},{"issue":"2","key":"3713_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.34172\/jcvtr.2020.22","volume":"12","author":"A Tajlil","year":"2020","unstructured":"Tajlil A et al (2020) Nicotine and smoking in the COVID-19 era. J Cardiovasc Thorac Res 12(2):136\u2013139","journal-title":"J Cardiovasc Thorac Res"},{"issue":"5","key":"3713_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C et al (2020) Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 55(5):105954","journal-title":"Int J Antimicrob Agents"},{"issue":"6921","key":"3713_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421(6921):384\u2013388","journal-title":"Nature"},{"issue":"12","key":"3713_CR24","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1086\/430323","volume":"191","author":"DJ van Westerloo","year":"2005","unstructured":"van Westerloo DJ et al (2005) The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 191(12):2138\u20132148","journal-title":"J Infect Dis"},{"key":"3713_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.toxrep.2020.04.012","volume":"7","author":"K Farsalinos","year":"2020","unstructured":"Farsalinos K et al (2020) Editorial: nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 7:658\u2013663","journal-title":"Toxicol Rep"},{"key":"3713_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2021.112009","volume":"149","author":"G Lagoumintzis","year":"2021","unstructured":"Lagoumintzis G et al (2021) Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins. Food Chem Toxicol 149:112009","journal-title":"Food Chem Toxicol"},{"key":"3713_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.toxrep.2020.12.013","volume":"8","author":"N Alexandris","year":"2021","unstructured":"Alexandris N et al (2021) Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 8:73\u201383","journal-title":"Toxicol Rep"},{"issue":"5","key":"3713_CR28","doi-asserted-by":"publisher","first-page":"2000688","DOI":"10.1183\/13993003.00688-2020","volume":"55","author":"JM Leung","year":"2020","unstructured":"Leung JM et al (2020) ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 55(5):2000688","journal-title":"Eur Respir J"},{"issue":"7798","key":"3713_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"issue":"8","key":"3713_CR30","volume":"14","author":"D Nath","year":"2022","unstructured":"Nath D, Shivasekar M (2022) Role of cigarette smoking on serum angiotensin-converting enzyme and its association with inflammation and lipid peroxidation. Cureus 14(8):e27857","journal-title":"Cureus"},{"issue":"1","key":"3713_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13054-023-04739-5","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B et al (2023) The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications. Crit Care 27(1):453","journal-title":"Crit Care"},{"issue":"1","key":"3713_CR32","doi-asserted-by":"publisher","first-page":"2001560","DOI":"10.1183\/13993003.01560-2020","volume":"56","author":"D Lutchman","year":"2020","unstructured":"Lutchman D (2020) Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2? Eur Respir J 56(1):2001560","journal-title":"Eur Respir J"},{"issue":"5","key":"3713_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"D Batlle","year":"2020","unstructured":"Batlle D, Wysocki J, Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond) 134(5):543\u2013545","journal-title":"Clin Sci (Lond)"},{"issue":"7950","key":"3713_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","volume":"615","author":"T Brevini","year":"2023","unstructured":"Brevini T et al (2023) FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature 615(7950):134\u2013142","journal-title":"Nature"},{"issue":"6585","key":"3713_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M et al (2022) The immunology and immunopathology of COVID-19. Science 375(6585):1122\u20131127","journal-title":"Science"},{"issue":"10","key":"3713_CR36","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","volume":"22","author":"ME McMenamin","year":"2022","unstructured":"McMenamin ME et al (2022) Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis 22(10):1435\u20131443","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3713_CR37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s11684-022-0977-3","volume":"17","author":"Z Fu","year":"2023","unstructured":"Fu Z et al (2023) Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai. Front Med 17(3):562\u2013575","journal-title":"Front Med"},{"issue":"10229","key":"3713_CR38","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062","journal-title":"Lancet"},{"issue":"1","key":"3713_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12879-021-05992-1","volume":"21","author":"M Flook","year":"2021","unstructured":"Flook M et al (2021) Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality. BMC Infect Dis 21(1):342","journal-title":"BMC Infect Dis"},{"key":"3713_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015201","author":"B Tadayon Najafabadi","year":"2023","unstructured":"Tadayon Najafabadi B et al (2023) Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD015201","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-024-03713-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-024-03713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:08:55Z","timestamp":1732180135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-024-03713-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3713"],"URL":"https:\/\/doi.org\/10.1007\/s11739-024-03713-5","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no association that might pose a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital (I-23PJ234).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Obtaining informed consent was waived by the Institutional Review Board of Peking Union Medical College Hospital because the data were anonymous and the study was retrospective.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in the present study were in accordance with the principles outlined in the 1964 Helsinki Declaration and its later amendments. The study was approved by the Ethics Committee of Peking Union Medical College Hospital (I-23PJ234).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Obtaining informed consent was waived by the ethics\/ IRB committee because the data were anonymous and this study was retrospective.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}